Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Meta Reportedly Developing ‘Arena’ Prediction Market App to Rival Polymarket and Kalshi 
DENVER, Feb. 24, 2016 -- BioScrip, Inc. (NASDAQ:BIOS) announced today that the Company will release its 2015 fourth quarter and year-end financial results on Wednesday, March 2, 2016, after the close of the U.S. financial markets.
Richard M. Smith, President and Chief Executive Officer, and Jeffrey M. Kreger, Chief Financial Officer and Treasurer, will conduct a conference call as follows:
| Date | Thursday, March 3, 2016 |
| Time | 8:30 a.m. EST |
| Toll free (U.S.) | 888-372-9592 |
| International | 918-559-5628 |
| Webcast (live and replay) | www.bioscrip.com |
A replay of the conference call will be available for one week after the call's completion by dialing 855-859-2056 (US) or 404-537-3406 (International) and entering conference call ID number 55165908. An audio webcast and archive will also be available for 30 days under the "Investor Relations" section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. is a leading national provider of infusion and home healthcare management solutions. BioScrip partners with healthcare providers, including physicians, hospital systems, skilled nursing facilities, and with healthcare payors to provide patients better access to high quality, efficient post-acute care services. BioScrip operates with a commitment to bring infusion therapy services into the home or alternate-site settings. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Contact: Lisa Wilson In-Site Communications, Inc. T: 212-452-2793 E: [email protected]
